HER2 recruits AKT1 to disrupt STING signalling and suppress antiviral defence and antitumour immunity

Shiying Wu(The University of Texas Southwestern Medical Center), Pinglong Xu(Zhejiang University-University of Edinburgh Institute), Jun Qin(Army Medical University), Qingzhe Wu(Zhejiang International Studies University), Jun Huang(Fujian Medical University), Xin‐Hua Feng(Zhejiang University), Hai Song(Zhejiang Cancer Hospital), Ruyuan Zhou(Zhejiang University), Shengduo Liu(Zhejiang University), Xinran Li(Shanghai University), Fei Zhang(Zhejiang Lab), Li Shen(University of California, Los Angeles), Jian Zou(University of Pittsburgh), Fansen Meng(Chinese PLA General Hospital), Zongping Xia(First Affiliated Hospital of Zhengzhou University), Qian Zhang(Jilin University), Songying Ouyang(Fujian Normal University)
Nature Cell Biology
July 22, 2019
Cited by 280


Related Papers